NCT06517875
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06517875
Title Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis (ODYSSEY)
Acronym ODYSSEY
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN

Facility Status City State Zip Country Details
GSK Investigational Site RECRUITING Nashville Tennessee 37203 United States Details
GSK Investigational Site RECRUITING Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site RECRUITING Angers 49933 France Details
GSK Investigational Site RECRUITING Brest 29609 France Details
GSK Investigational Site RECRUITING Lyon 69004 France Details
GSK Investigational Site RECRUITING Nice 06202 France Details
GSK Investigational Site RECRUITING Nîmes 30029 France Details
GSK Investigational Site RECRUITING Paris 75010 France Details
GSK Investigational Site RECRUITING Poitiers 86021 France Details
GSK Investigational Site RECRUITING Roma 161 Italy Details
GSK Investigational Site RECRUITING Málaga 29010 Spain Details
GSK Investigational Site RECRUITING Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field